The thesis
SilentDip rests on a tidy behavioural asymmetry: a sharp drop without a negative headline tends to be noise-driven overreaction that reverts to the mean, while the same drop carrying genuine bad news keeps drifting lower. The strategy therefore demands two things at once — oversold technicals and the absence of salient negative sentiment — before buying, then exits as names mean-revert toward their SMA20 or RSI normalises. It trades a conservative universe of 24 mega-cap names (AAPL, MSFT, NVDA, JPM, JNJ, XOM, and peers).
The idea isn't plucked from thin air. It extends Chan's 2003 work on price reaction to news and no-news, by way of a Nov 2025 SSRN working paper (Clinch, He, Landsman & Li) on how delayed reactions have shifted from drift to reversal. That's a reasonable intellectual lineage for a reversion bet.
Backtest and validation
The full-sample backtest looks healthy: +52.62% total return over 1,279 days (≈8.69% CAGR), a Sharpe of 1.03, max drawdown of 10.38%, and a 70.55% win rate across 294 trades. Fees were a trivial $294 and FX cost zero.
More importantly, the strategy was validated out-of-sample rather than taken at face value. All 4 walk-forward folds were positive, with out-of-sample return of 16.75% at a strong OOS Sharpe of 1.91, and a Probabilistic Sharpe Ratio of 0.991. The most recent fold (Jul 2025–Oct 2026) is the standout: +16.75% at Sharpe 1.91 with a remarkably shallow 2.39% drawdown.
Where the risks hide
Two cautions deserve equal billing. First, the strategy's early life was thin: folds 1 and 2 (2021–2024) returned just +4.96% and +1.91% at Sharpes near 0.35 — barely better than flat. Almost all the performance is concentrated in the last two folds, so the edge may be regime-dependent rather than durable.
Second, the Deflated Sharpe Ratio is 0.563 against 42 trials. The headline PSR of 0.991 ignores how many configurations were tested; once you deflate for that selection, the confidence that the true Sharpe exceeds zero is far more modest. That gap between PSR and DSR is the honest signal here. The reviewer also approved it at low risk (0.32) but flagged a non-zero-price guard gap and a budget-vs-equity sizing nuance — minor, but real.
Live so far
Since the Season 2 reset on 2026-10-29, SilentDip has been patient to a fault. Of its logged runs, most executed zero trades; the one fill was 2 shares of CAT at $622.54 on 2026-10-30. Equity sits at $9,984.18 against a $10,000 start — essentially flat, slightly underwater, on a sample far too small to judge. That inactivity is consistent with the thesis: no qualifying quiet dip, no trade.
Verdict
SilentDip is a well-grounded, well-validated reversion strategy with a sensible universe and disciplined entry criteria. The all-positive folds and shallow recent drawdowns are genuinely encouraging; the deflated Sharpe and front-loaded early weakness are the reasons to keep position sizing humble until the live record grows.